%0 Journal Article
%T PABPC4及MYC诱导形成的肝癌的研究进展<br>Research Progress of PABPC4 and Hepatocellular Carcinoma Induced by MYC
%A 刘瑞瑞
%J Advances in Clinical Medicine
%P 1453-1461
%@ 2161-8720
%D 2024
%I Hans Publishing
%R 10.12677/ACM.2024.141209
%X 肝癌是影响人们健康的最常见癌症之一，具有高侵袭性、预后差及治疗选择有限的临床特点，已成为全球第六大常见癌症，致死率居全球第三。c-Myc是肝细胞肝癌(HCC)发育中的一个重要致癌基因，在18%的人类HCC中被发现被扩增或上调，但同时c-Myc是一种多效性转录因子，对正常细胞增殖和维持干细胞至关重要，尽管c-Myc抑制剂现在正在临床上进行测试，但仍有可能具有局限性。c-Myc致瘤作用及其下游调控的基因和信号通路仍有待充分研究，寻找新的早期诊断和靶向治疗分子等为肝癌的预防和治疗带来新的方法和策略。细胞质多聚腺苷酸结合蛋白4 (PABPC4)是一种RNA加工蛋白，在调节基因表达中起重要作用。越来越多的证据表明了PABPC4在肿瘤发生中的独特作用。本综述的目的是解释c-Myc在肿瘤发展中的作用以及PABPC4的研究现状。<br />
Hepatocellular carcinoma is one of the most common cancers affecting people’s health. It has be-come the sixth most common cancer in the world and the third deadliest cancer in the world due to its high aggressiveness, poor prognosis and limited treatment options. c-Myc is an important onco-gene in HCC development and has been found to be amplified or upregulated in 18% of human HCC, but at the same time, c-Myc is a pleiotropic transcription factor that is essential for normal cell pro-liferation and maintenance of stem cells, and although c-Myc inhibitors are now being tested clini-cally, they are still likely to have limitations. The oncogenic effect of c-Myc and its downstream reg-ulation of genes and signaling pathways remain to be fully studied, and new early diagnosis and targeted therapeutic molecules are sought to bring new methods and strategies for the prevention and treatment of liver cancer. Cytoplasmic PABPC4 is an RNA processing protein that plays an im-portant role in regulating gene expression. There is increasing evidence for the unique role of PABPC4 in tumorigenesis. The purpose of this review is to explain the role of c-Myc in tumor devel-opment and the current status of PABPC4 research.
%K 肝细胞肝癌，MYC，PABPC4<br>Hepatocellular Carcinoma
%K MYC
%K PABPC4
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=79948